.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Manuel Krone

Würzburg, DE

Universitätsklinikum Würzburg

Einsätze

18.09.2023

13:30 – 15:00
Workshop
Infection Prevention and Control (IPC) and respiratory Infections (FG PR HY/StAG Hyg) 1
Seminarraum 2
IPC and respiiratory infections (FG PR HY/StAG Hyg)
14:22 – 14:35 10 Min. 3 Min.
Vortrag
PRHYV 027
Quality of life and ability to work after SARS-CoV-2 infections – six-month data from a prospective, controlled cohort study
IPC and MDRO and nosocomial pathogens (FG PR HY/StAG Hyg)
Poster
DKMDVP 136
Guideline alignment for inoculated blood culture volumes in pediatrics – a pilot study
Progress in pathogen diagnostics (FG DKM/StAG DV/jDGHM)

19.09.2023

Poster
IIP 261
Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster
Infektionsimmunologie, Wirt-basierte Therapien, Impfstoffe (FG II)

20.09.2023

10:15 – 10:30 10 Min. 5 Min.
Vortrag
DKMDVV 126
Influence of symptoms, vaccination, and Omicron BA.1/2 and BA.4/5 on SARS-CoV-2 antigen rapid tests
Progress in pathogen diagnostics (FG DKM/StAG DV/jDGHM)